ArticleMolecular biology reports2026
Exercise therapy-associated changes in Periostin (POSTN) osteoarthritis are linked to Hippo-YAP signaling.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteoarthritis (OA) is characterized by progressive extracellular matrix (ECM) degradation, chondrocyte apoptosis, and hypertrophic differentiation, yet the molecular basis underlying the protective effects of exercise therapy remains incompletely understood. Given that periostin (POSTN) is a mechanosensitive extracellular matrix protein implicated in OA progression and that Hippo-YAP signaling is a key regulator of mechanotransduction and cartilage homeostasis, their potential involvement in exercise-mediated chondroprotection warrants investigation.
aimThis study aims to investigate the association between exercise therapy and osteoarthritis progression, with a focus on POSTN and the Hippo-YAP signaling pathway.
methodsBioinformatics analysis was performed using the GSE169077 dataset to identify candidate genes in OA. An anterior cruciate ligament transection (ACLT)-induced rat OA model with treadmill exercise intervention and an IL-1β-induced OA-like C28/I2 chondrocyte model with cyclic tensile strain (CTS) stimulation were established. POSTN expression was detected by RT-qPCR, Western blot, and immunohistochemistry. The roles of POSTN and Hippo-YAP signaling pathways in ECM metabolism, apoptosis, hypertrophic differentiation, and YAP nuclear translocation were evaluated by POSTN overexpression and vertexporfin-mediated YAP inhibition.
resultsBioinformatics analysis identified COL1A1, MMP2, MMP9, and POSTN as upregulated genes in OA. POSTN expression was increased in both rat OA cartilage and IL-1β-induced OA-like chondrocytes and was significantly suppressed by exercise intervention in vivo and CTS in vitro. In interleukin-1β (IL-1β)-induced OA-like chondrocytes, CTS reduced the expression of matrix degradation-related proteins (ADAMTS5 and MMP13), increased Aggrecan and Collagen II levels, inhibited apoptosis (decreased Bax, Cytochrome c, and cleaved caspase-3 and increased Bcl-2), and attenuated hypertrophic differentiation (decreased RUNX2 and COL10A1 and increased SOX9). These protective effects were partially reversed by POSTN overexpression. Mechanistically, CTS decreased the p-LATS1/LATS1 and p-YAP/YAP ratios, restored YAP expression, and promoted its nuclear translocation, whereas POSTN overexpression attenuated these effects. Furthermore, verteporfin exacerbated POSTN overexpression-induced extracellular matrix degradation and hypertrophic differentiation. Consistent with the in vitro findings, exercise intervention in vivo reduced the expression of the hypertrophic markers MMP13 and RUNX2 while restoring the expression of SOX9, Collagen II, and YAP in OA cartilage.
conclusionThese findings suggest that exercise therapy may be associated with changes in chondrocyte catabolic and hypertrophic processes in osteoarthritis, potentially involving the suppression of POSTN and modulation of the Hippo-YAP signaling pathway.
Indexed as
Identifiers
42484941What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.